With Another Pharma Update, Possibility of Vaccine in Near Future Seems More Promising

After good news yesterday from AstraZeneca’s (AZN) camp on the company’s seal of approval from the EU and what that could mean for the potential roll-out of its coronavirus vaccine, another big pharmaceutical name comes reveals a critical vaccine update. This past July, Moderna (MRNA) launched its 30,000-person, late-stage, clinical trial in the U.S. testing the

Read More ›

Market Overview